Psilocybin in the Treatment of Cocaine Use Disorder: A Randomized Clinical Trial.
Hendricks PS +10 more
europepmc +1 more source
A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience. [PDF]
Back AL +15 more
europepmc +1 more source
Correction to: Preliminary Evidence of Sleep Improvements Following Psilocybin Administration, and their Involvement in Antidepressant Therapeutic Action. [PDF]
Reid MJ +4 more
europepmc +1 more source
Psilocybin elicits a conserved glucocorticoid-responsive gene signature across five 5-HT2A receptor-rich brain regions in rat. [PDF]
Veysi A +4 more
europepmc +1 more source
Psilocybin shapes the slow, global propagation of brain activity over the cortical layout of 5HT2a receptors. [PDF]
Mäki-Marttunen V.
europepmc +1 more source
Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression. [PDF]
Morel NS +3 more
europepmc +1 more source
Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake. [PDF]
Bergh MS +3 more
europepmc +1 more source
Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial. [PDF]
Weintraub MJ +13 more
europepmc +1 more source

